Patients with hematologic malignancies can be cured with unrelated donor (URD) marrow transplantation. Compared to transplantation from related donors, however, URD transplantation is associated with an increased risk of complications including acute and chronic graft-versus-host disease (GVHD), graft failure, and the need for prolonged immunosuppression. Recently, clinical studies have demonstrated the importance of HLA genes in influencing transplant outcome. Donor-recipient matching for the class II gene HLA-DRB1 reduces the risk of acute GVHD and improves survival, whereas mismatching for the class I genes HLA-A, B and C increases the risk of graft failure. In addition to the classical HLA genes, disparity for other genes may contribute to an increased risk of complications since HLA-A, B, C, DRB and DQB1 genotypically matched URD recipients still develop GVHD and experience graft failure. Because of the fundamental role of MHC class I and related molecules in antigen presentation and T cell recognition, HLA-E and MIC are of immediate immunological interest in the clinical transplant setting. The overall goal of this project is to determine the extent to which URD marrow transplantation can be optimized by more complete donor-recipient matching of MHC region genes. PCR-based technology will be developed to sequence HLA-E and MIC (Specific Aim l). The extent of polymorphism, the association of alleles on haplotypes and the degree of mismatching for HLA-E and-MIC alleles in URD transplant pairs will be determined (Specific Aim 2). Finally, the effect of mismatching for HLA-E and MIC alleles on the development of GVHD, graft failure and survival after marrow transplantation will be studied (Specific Aim 3). The studies proposed in this application will provide important new information concerning the biological relevance of class I region genes in the immune response and offer new approaches for improving the overall outcome of marrow transplantation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA072978-03
Application #
2871929
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Wu, Roy S
Project Start
1997-02-01
Project End
2004-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Malkki, Mari; Gooley, Ted A; Horowitz, Mary M et al. (2007) Mapping MHC-resident transplantation determinants. Biol Blood Marrow Transplant 13:986-95
Petersdorf, Effie W; Anasetti, Claudio; Martin, Paul J et al. (2004) Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 104:2976-80
Guo, Zhen; Gatterman, Mark S; Hood, Lee et al. (2002) Oligonucleotide arrays for high-throughput SNPs detection in the MHC class I genes: HLA-B as a model system. Genome Res 12:447-57
Mickelson, Eric M; Petersdorf, Effie W; Hansen, John A (2002) HLA matching and hematopoietic cell transplant outcome. Clin Transpl :263-71
Holmes, Margaret A; Li, Pingwei; Petersdorf, Effie W et al. (2002) Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D. J Immunol 169:1395-400
Petersdorf, E W; Hansen, J A; Martin, P J et al. (2001) Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 345:1794-800
Petersdorf, E W; Gooley, T; Malkki, M et al. (2001) The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 112:988-94
Petersdorf, E W; Mickelson, E M; Anasetti, C et al. (1999) Effect of HLA mismatches on the outcome of hematopoietic transplants. Curr Opin Immunol 11:521-6
Petersdorf, E W; Shuler, K B; Longton, G M et al. (1999) Population study of allelic diversity in the human MHC class I-related MIC-A gene. Immunogenetics 49:605-12
Petersdorf, E W; Gooley, T A; Anasetti, C et al. (1998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92:3515-20